ORBIMED ADVISORS LLC Q3 2025 Filing

Filed November 14, 2025

Portfolio Value

$4.3T

Holdings

104

Report Date

Q3 2025

Filing Type

13F-HR

All Holdings (104 positions)

#StockSharesValue% PortfolioType
101
LYELLYELL IMMUNOPHARMA INC
51,727$840.0M0.02%
102
KZRKEZAR LIFE SCIENCES INC
192,700$751.5M0.02%
103
XERSXERIS BIOPHARMA HOLDINGS INC
80,420$654.6M0.02%
104
PASGPASSAGE BIO INC
59,046$474.1M0.01%
105
—DIH HLDG US INC
1,915,000$358.1M0.01%
PreviousPage 2 of 2